Motilal Oswal maintains a 'Buy' rating on CIE Automotive India with a target price of Rs 575. Anticipating growth driven by Indian operations, but tempered by weakness in the European market, the brokerage slightly lowered its earnings estimates. CIE's strong financial position, including being net debt-free and generating positive free cash flow, supports the positive outlook.

Motilal Oswal maintains a buy call on Indian Hotels Company (IHCL) with a target price of Rs 950. The brokerage expects strong growth in the second half of FY25 and FY26, driven by rising room rates, corporate hikes, renovations, and operating leverage. IHCL reported a 27.64% YoY increase in total income and a net profit of Rs 573.

Motilal Oswal recommends buying Happy Forgings stock, setting a target price of Rs 1,300, significantly higher than the current Rs 1,030 market price. This small-cap auto ancillary company reported increased total income and a healthy net profit in the recent quarter. Promoters hold a substantial 78.6% stake, with FIIs and DIIs also invested.

HDFC Securities sets a Rs 4000 target for Mastek. The firm anticipates margin recovery starting in the fourth quarter. Revenue and EPS are projected to grow. Mastek's Q3 margins will be impacted by wage hikes. The company reported increased total income and net profit. Uncertainty remains regarding new CEO and CFO appointments.

Motilal Oswal maintains a buy rating on Dabur India with a target price of Rs 675. Dabur reported lower Q2 FY25 earnings due to weak demand, particularly in urban areas and a delayed winter season. Despite inventory corrections and lowered EPS estimates, the brokerage sees value after the recent stock correction.

JM Financial sets a Rs 2500 target for Ami Organics shares. Nubeqa drug expansion and a new contract are expected to boost growth. Ami Organics reported strong quarterly results, with income up 47% year-on-year. Profits reached Rs 37.57 crore. Analysts revised estimates upwards due to the promising outlook. The company's market cap stands at Rs 8556.10 crore.

Axis Securities gives JTL Industries a buy rating with a target price of Rs 111, a 10% upside. JTL Industries, a small-cap steel tube manufacturer, plans to expand its capacity to 1 MTPA by FY25 and 2 MTPA by FY27. The company reported a slight decline in total income and a net profit of Rs 26.

ICICI Securities has given a 'buy' rating for Solar Industries India, setting a target price of ₹13,250. The brokerage firm believes the market is underestimating the company's potential, particularly concerning defense-related export orders. These orders, along with domestic orders, are projected to significantly boost revenue and maintain high profit margins over the next four years.

ICICI Securities initiates coverage on Himadri Specialty Chemical with an "ADD" rating and a target price of Rs 600. Himadri's integrated model and expansion into export markets are expected to boost profitability. The company is also scaling its specialty carbon black capacity and venturing into new businesses like tires and battery chemicals.

Motilal Oswal Financial Services has given a buy call for Kirloskar Oil Engines stock with a target price of Rs 1,540. The stock is currently trading at a significant discount compared to the market leader. They anticipate growth driven by higher HP segments, exports, and the B2C segment. Promoters hold a 41.17% stake in the company.

JM Financial reaffirms its buy rating for Oil India, setting a target price of Rs 615. The brokerage anticipates strong production growth and stable crude oil prices. Oil India's refinery expansion is expected to boost earnings. However, lower crude prices could impact profitability. The company's current market price is Rs 457.95.

ICICI Securities maintains a buy rating for Awfis Space Solutions, raising the target price to Rs 1049 from Rs 730.2. Awfis reported strong H1FY25 results, exceeding revenue growth and EBITDA margin guidance. With a robust operational pipeline of over 110,000 seats, ICICI Securities projects continued growth, estimating a 31% revenue CAGR through FY27.

Motilal Oswal recommends buying Lemon Tree Hotels stock, setting a target price of Rs 190 compared to its current market price of Rs 154.25. The hotel chain reported strong Q2 earnings, with profit up 23.78% year-over-year. Analysts predict continued growth for the hospitality sector, driven by economic activity and improved infrastructure.

Motilal Oswal recommends buying Lemon Tree Hotels stock, setting a target price of Rs 190 compared to its current market price of Rs 154.25. The hotel chain reported strong Q2 earnings, with profit up 23.78% year-over-year. Analysts predict continued growth for the hospitality sector, driven by economic activity and improved infrastructure.

Axis Securities has given a "buy" rating for Healthcare Global Enterprises (HCG) stock, setting a target price of Rs 575. HCG, a major player in the rapidly growing cancer care industry, plans to expand its capacity significantly. With anticipated improvements in profitability, the brokerage sees a 14% upside potential from the current market price.

ICICI Securities maintains a buy rating for Awfis Space Solutions, raising the target price to Rs 1049 from Rs 730.2. Awfis reported strong H1FY25 results, exceeding revenue growth and EBITDA margin guidance. With a robust operational pipeline of over 110,000 seats, ICICI Securities projects continued growth, estimating a 31% revenue CAGR through FY27.

JM Financial sets a Rs 2500 target for Ami Organics shares. Nubeqa drug expansion and a new contract are expected to boost growth. Ami Organics reported strong quarterly results, with income up 47% year-on-year. Profits reached Rs 37.57 crore. Analysts revised estimates upwards due to the promising outlook. The company's market cap stands at Rs 8556.10 crore.

Motilal Oswal maintains a buy call on Indian Hotels Company (IHCL) with a target price of Rs 950. The brokerage expects strong growth in the second half of FY25 and FY26, driven by rising room rates, corporate hikes, renovations, and operating leverage. IHCL reported a 27.64% YoY increase in total income and a net profit of Rs 573.

JM Financial recommends buying Piramal Pharma stock. The target price is Rs 340. The current market price is Rs 260.55. India's CRDMO industry is expected to double by 2028. Piramal Pharma is well-positioned for growth. The company's CDMO business is a key driver. JM Financial projects a 15% topline growth and 23%+ EBITDA CAGR over FY24-27.

ICICI Securities initiates coverage on Himadri Specialty Chemical with an "ADD" rating and a target price of Rs 600. Himadri's integrated model and expansion into export markets are expected to boost profitability. The company is also scaling its specialty carbon black capacity and venturing into new businesses like tires and battery chemicals.